Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Patients with high-risk prostate cancer treated with curative intent are at an increased risk of
biochemical recurrence, metastatic progression and cancer-related death compared with …

Despite substantial progress in the treatment of castration-resistant prostate cancer (CRPC),
including radiation therapy and immunotherapy alone or in combination, the response to …

Prostate cancer (PCa) is a high morbidity malignancy in males, and biochemical recurrence
(BCR) may appear after the surgery. Our study is designed to build up a risk score model …

Background and purpose With daily, MR-guided online adapted radiotherapy (MRgART) it
may be possible to reduce the PTV in pelvic RT. This study investigated the potential …

Context Optimal management of prostate cancer (PCa) patients with lymph node invasion at
radical prostatectomy and pelvic lymph node dissection still remains unclear. Objective To …

Chimeric antigen receptor (CAR) T cell immunotherapy involves the genetic modification of
the patient's own T cells so that they specifically recognize and destroy tumour cells …

Purpose: We sought to compare outcomes between neoadjuvant therapy with a novel
hormonal agent (NHA) prior to radical prostatectomy (neo-RP) and up-front radical …

Prostate cancer (PCa) is a common high-incidence malignancy in men, some of whom
develop biochemical recurrence (BCR) in the advanced stage. However, there are currently …

Optimization of treatment strategies for prostate cancer patients treated with curative
radiation therapy (RT) represents one of the major challenges for the radiation oncologist …